Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

60
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

51
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
51
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

68
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
68
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

79
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geometry-Aware Abdominal Aortic Aneurysm Digital Twin for Patient-Specific Wall Stress Mapping.

Research square·2026
Same author

Forecasting Patient-Specific Abdominal Aortic Aneurysm Geometry with Mixed-Effects Models.

Diagnostics (Basel, Switzerland)·2026
Same author

The Society for Vascular Surgery clinical practice guideline on the management of blunt thoracic aortic injury: Focused update.

Journal of vascular surgery·2026
Same author

Geometry quantification for growth assessment of abdominal aortic aneurysms under surveillance.

Scientific reports·2026
Same author

An Integrated Framework for Automated Image Segmentation and Personalized Wall Stress Estimation of Abdominal Aortic Aneurysms.

Bioengineering (Basel, Switzerland)·2026
Same author

Automatic Explainable Segmentation of Abdominal Aortic Aneurysm From Computed Tomography Angiography.

IEEE access : practical innovations, open solutions·2026

Related Experiment Video

Updated: Oct 19, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.6K

Direct oral anticoagulants decrease treatment failure for acute lower extremity deep venous thrombosis.

Katherine E Hekman1, Calvin L Chao1, Courtney E Morgan2

  • 1Department of Surgery, Division of Vascular Surgery, 12244Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Vascular
|September 27, 2021
PubMed
Summary

Direct oral anticoagulants (DOACs) show improved outcomes for acute lower extremity deep venous thrombosis (DVT) compared to traditional therapies. DOACs significantly reduced treatment failures within three months, offering a more effective medical therapy option.

Keywords:
deep venous thrombosisdirect oral anticoagulantduplex ultrasound

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.5K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.9K

Related Experiment Videos

Last Updated: Oct 19, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.5K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.9K

Area of Science:

  • Vascular Medicine
  • Pharmacology
  • Medical Imaging

Background:

  • Optimal medical therapy for acute lower extremity deep venous thrombosis (DVT) is not definitively established.
  • Clinical trials suggest non-inferiority of direct oral anticoagulants (DOACs) versus traditional anticoagulation regimens.

Purpose of the Study:

  • To compare the effectiveness of different anticoagulant therapies for acute lower extremity DVT.
  • To assess treatment failure rates within three months of diagnosis across various anticoagulant treatments.

Main Methods:

  • Retrospective cohort study of 496 patients diagnosed with acute lower extremity DVT.
  • Analysis of demographics, medical history, and primary anticoagulant treatment (VKA, DOAC, LMWH, etc.).
  • Treatment failure defined as new or progressive DVT within 3 months, assessed via serial lower extremity venous duplex ultrasound.

Main Results:

  • Direct oral anticoagulants (DOACs) were associated with significantly lower treatment failure rates (OR 0.43) compared to all other treatments.
  • DOACs showed a statistically significant reduction in treatment failure compared to traditional oral vitamin K antagonists (VKAs) (OR 0.44).
  • No correlation found between treatment failure and prior DVT history, pulmonary embolism, thrombophilia, renal/hepatic insufficiency, cancer, antiplatelet therapy, anticoagulation duration, or DVT location (proximal vs. distal).

Conclusions:

  • Direct oral anticoagulants (DOACs) demonstrate superior outcomes in treating acute lower extremity DVT compared to traditional oral vitamin K antagonist (VKA) therapy.
  • DOACs significantly reduced treatment failures at 3 months, as evidenced by serial duplex imaging.
  • DOACs represent a more effective medical therapy option for acute lower extremity DVT.